Induction of an antigen-specific immune response and partial protection of cattle against challenge infection with foot-and-mouth disease virus (FMDV) after lipopeptide vaccination with FMDV-specific B-cell epitopes

References

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D. J., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2·9 Å resolution. Nature 337:709–716
   [Google Scholar]
2. Aliprantis A. O., Yang R. B., Mark M. R., Suggett S., Devaux B., Radolf J. D., Klimpel G. R., Godowski P., Zychlinsky A. 1999; Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor-2. Science 285:736–739
   [Google Scholar]
3. Barteling S. J., Vreeswijk J. 1991; Developments in foot-and-mouth disease vaccines. Vaccine 9:75–88
   [Google Scholar]
4. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
   [Google Scholar]
5. Brown F. 1992; New approaches to vaccination against foot-and-mouth disease. Vaccine 10:1022–1026
   [Google Scholar]
6. Collen T. 1994; Foot-and-mouth disease virus (aphthovirus): viral T cell epitopes. In Cell-Mediated Immunity in Ruminants pp  173–197 Edited by Goddeeris B. M. I., Morrison I. Boca Raton: CRC Press;
   [Google Scholar]
7. Collen T., DiMarchi R., Doel T. R. 1991; A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. J Immunol 146:749–755
   [Google Scholar]
8. De Mattia F., Chomez S., Van Laethem F., Moulin V., Urbain J., Moser M., Leo O., Andris F. 1999; Antigen-experienced T cells undergo a transient phase of unresponsiveness following optimal stimulation. J Immunol 163:5929–5936
   [Google Scholar]
9. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
   [Google Scholar]
10. Doel T. R., Gale C., Do Amaral C. M. C. F., Mulcahy G., DiMarchi R. 1990; Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. J Virol 64:2260–2264
    [Google Scholar]
11. Domingo E., Mateu M. G., Martínez M. A., Dopazo J., Moya A., Sobrino F. 1990 Applied Virology Research , vol. 2 pp  233–266 Edited by Kurstak E., Marusyk R. G., Murphy B. New York: Plenum;
    [Google Scholar]
12. Forss S., Strebel K., Beck E., Schaller H. 1984; Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic Acids Res 12:6587–6601
    [Google Scholar]
13. Hamblin C., Barnett I. T., Hedger R. S. 1986; A new enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies against foot-and-mouth disease virus. I. Development and method of ELISA. J Immunol Methods 93:115–121
    [Google Scholar]
14. McCullough K. C., Bruckner L., Schaffner R., Fraefel W., Müller H. K., Kihm U. 1992; Relationship between the anti-FMD virus antibody reaction as measured by different assays, and protection in vivo against challenge infection. Vet Microbiol 30:99–112
    [Google Scholar]
15. Merrifield R. B., Stewart J. M. 1965; Automated peptide synthesis. Nature 207:522–523
    [Google Scholar]
16. Morgan D. O., Moore D. M. 1990; Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines. Am J Vet Res 51:40–45
    [Google Scholar]
17. Pereira H. G. 1981; Virus Diseases of Food Animals . pp  333–363 Edited by Gibbs E. P. London, UK: Academic Press;
18. Pfaff E., Mussgay M., Böhm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO J 1:869–874
    [Google Scholar]
19. Riley E. M. 1996; The role of MHC- and non-MHC-associated genes in determining the human immune response to malaria antigens. Parasitology 112:39–51
    [Google Scholar]
20. Sobrino F., Blanco E., Garcia-Briones M., Ley V. 1999; Synthetic peptide vaccines: foot-and-mouth disease virus as a model. Dev Biol Stand 101:39–43
    [Google Scholar]
21. Strohmaier K., Franze R., Adam K. H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. J Gen Virol 59:295–306
    [Google Scholar]
22. Taboga O., Tami C., Carrello E. 13 other authors 1997; A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants. J Virol 71:2606–2614
    [Google Scholar]
23. Volpina O. M., Surovoy A. Y., Zhmak M. N., Kuprianova M. A., Koroev D. O., Chepurkin A. V., Toloknov A. S., Ivanov V. T. 1999; A peptide construct containing B-cell and T-cell epitopes from the foot-and-mouth disease viral VP1 protein induces efficient antiviral protection. Vaccine 17:577–584
    [Google Scholar]
24. Wiesmüller K.-H., Jung G., Hess G. 1989; Novel low-molecular-weight synthetic vaccine against foot-and-mouth disease containing a potent B-cell and macrophage activator. Vaccine 7:29–33
    [Google Scholar]
25. Wiesmüller K.-H., Bessler W. G., Jung G. 1992; Solid phase peptide synthesis of lipopeptide vaccines eliciting epitope-specific B-, T-helper and T-killer cell response. Int J Pept Protein Res 40:255–260
    [Google Scholar]